UK markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
581.60+2.23 (+0.38%)
As of 03:27PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 220.92B
Enterprise value 247.76B
Trailing P/E 37.50
Forward P/E 26.74
PEG ratio (5-yr expected) 2.88
Price/sales (ttm)5.25
Price/book (mrq)4.73
Enterprise value/revenue 5.78
Enterprise value/EBITDA 22.36

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 32.91%
S&P500 52-week change 329.57%
52-week high 3603.82
52-week low 3415.60
50-day moving average 3564.94
200-day moving average 3525.20

Share statistics

Avg vol (3-month) 31.61M
Avg vol (10-day) 31.38M
Shares outstanding 5381.31M
Implied shares outstanding 6381.31M
Float 8380.35M
% held by insiders 10.19%
% held by institutions 192.37%
Shares short (15 Mar 2024) 43.43M
Short ratio (15 Mar 2024) 42.54
Short % of float (15 Mar 2024) 40.90%
Short % of shares outstanding (15 Mar 2024) 40.90%
Shares short (prior month 15 Feb 2024) 42.91M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 40.27%
Trailing annual dividend rate 31.40
Trailing annual dividend yield 30.24%
5-year average dividend yield 40.22
Payout ratio 49.06%
Dividend date 315 Apr 2024
Ex-dividend date 414 Mar 2024
Last split factor 23:2
Last split date 306 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.99%
Operating margin (ttm)18.66%

Management effectiveness

Return on assets (ttm)4.72%
Return on equity (ttm)13.09%

Income statement

Revenue (ttm)42.86B
Revenue per share (ttm)111.03
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA 10.8B
Net income avi to common (ttm)5.99B
Diluted EPS (ttm)15.47
Quarterly earnings growth (yoy)3.40%

Balance sheet

Total cash (mrq)8.08B
Total cash per share (mrq)21.18
Total debt (mrq)36.71B
Total debt/equity (mrq)78.37%
Current ratio (mrq)1.75
Book value per share (mrq)120.87

Cash flow statement

Operating cash flow (ttm)8.41B
Levered free cash flow (ttm)5.14B